Magna Diagnostics coordinates a BMBF-funded R&D project, which focuses on the development of the diagnostic platform for fast diagnosis of sepsis. The diagnostic platform - MAZER system - is composed of two elements: A one-time use disposable “plastic card”, or MinoCard on which the reagents, magnetic nanoparticles and the innovative biochip are located.
The second element is a hand-held analysis device, the MinoLyzer or “reader device”, in which the MinoCard is inserted following application of the patient sample. All diagnostic processes that follow occur fully-automatically through magnetic guidance and the end diagnostic result is displayed on a readout display of the MinoLyzer. With the assistance of the MAZER system, it is possible to detect and quantify simultaneously, as opposed to current typical DNA and protein diagnostic procedures. In contrast to conventional platforms the signal readout occurs fully electrically though the cost-saving analysis device which functions without voluminous optics or time-consuming measurement procedures. The uniqueness of the MAZER system lies in its ability to deliver diagnostic results at the point-of-care that through integration of complex preparation processes on a closed platform and the parallel diagnosis of many biological parameters. [more]